d.karlsen
Submits third-party assay reports on material purchased directly. Based in Angers.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.87%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043474 | CJC-1295 with DAC | BCH | BCH-2607-H5235 | Janoshik | 2026-Q3 | 97.82 | 6.05 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042130 | ARA-290 | JEEP | JEEP-2601-K8319 | Janoshik | 2026-Q2 | 99.24 | 4.65 | 92.5 | Buyer-sourced | 0 | PASS |
| AX-2026-041528 | Retatrutide | QSC | QSC-2511-M6429 | VendorInvestigate | 2026-Q1 | 99.65 | 1.24 | 106.7 | Buyer-sourced | 0 | PASS |
| AX-2025-018686 | Survodutide | QSC | QSC-2506-B6880 | Medutest | 2025-Q4 | 98.04 | 5.99 | 105.3 | Buyer-sourced | 0 | PASS |
| AX-2025-020347 | BPC-157 | MKM | MKM-2502-T3877 | Janoshik | 2025-Q3 | 98.60 | 6.61 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020243 | Retatrutide | GGPeps | GGPE-2508-E1731 | Medutest | 2025-Q3 | 98.12 | 2.82 | 93.6 | Buyer-sourced | 0 | PASS |
| AX-2025-018914 | CJC-1295 with DAC | TFS | TFS-{CAT}-1220 | Janoshik | 2025-Q2 | 98.87 | 4.81 | 103.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018429 | NAD+ | WWB | WWB-2504-B2388 | PeptideMeter | 2025-Q2 | 99.26 | 11.28 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-019496 | Liraglutide | JEEP | JEEP-2411-B9021 | Janoshik | 2025-Q2 | 99.13 | 5.05 | 90.5 | Buyer-sourced | 0 | PASS |